Yuya Seko

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 709 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma

Yusuke Kawamura, Yasuji Arase, Kenji Ikeda et al. · The American Journal of Gastroenterology · 2011 · 279 citations

Medicine, Oncology, Cancer Epidemiology +16

The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

Hiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka et al. · Journal of Gastroenterology · 2018 · 129 citations

Veterinary Medicine, Internal Medicine, Pathology +10

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study

Yasushi Honda, Takaomi Kessoku, Yoshio Sumida et al. · BMC Gastroenterology · 2017 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

Fumitaka Suzuki, Hitomi Sezaki, Norio Akuta et al. · Journal of Clinical Virology · 2012 · 110 citations

Life Sciences, Genetics, Infectious Diseases +15